Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology
Volume 16 (2002), Issue 8, Pages 555-558
http://dx.doi.org/10.1155/2002/459638
Controversies in Gastroenterology

Motion – All Patients with GERD Should Be Offered Once in a Lifetime Endoscopy: Arguments against the Motion

James W Freston

University of Connecticut Health Center, Farmington, Connecticut, USA

Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The evidence for the recommendation that patients with gastroesophageal reflux disease (GERD) be offered once in a lifetime endoscopy is weak and is not supported by any clinical trials. GERD is a very prevalent condition, yet only 10% of patients with GERD have Barrett’s esophagus (BE). Esophageal adenocarcinoma (EAC) is a rare condition and is uncommon even among patients with BE. A decision analysis found that surveillance of BE patients is performed because of inflated estimates of the rate of progression from BE to EAC. Dysplasia more often regresses to more benign histological findings than to cancer, and transient dysplasia can also lead to a high rate of unnecessary endoscopy. Even though practice guidelines about endoscopic surveillance have been published, there is no consensus among gastroenterologists about appropriate protocols, and many physicians are more aggressive than the guidelines. It has not been proved that surveillance saves lives, in part because BE rarely leads to death from EAC. The favourable results from some specialized centres may not be widely applicable. The recommendation for ‘once in a lifetime’ endoscopy for GERD patients is premature.